Bailard, Inc. Revolution Medicines, Inc. Transaction History

Bailard, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$24.35 - $33.7 $1.01 Million - $1.4 Million	-41,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $263,450 - $367,509	-11,000 Reduced 20.95%	41,500 $1.14 Million
Q2 2021 Aug 13, 2021	BUY	$29.0 - $47.44 $585,800 - $958,288	20,200 Added 62.54%	52,500 $1.67 Million
Q1 2021 May 13, 2021	BUY	$37.21 - $54.43 $111,630 - $163,290	3,000 Added 10.24%	32,300 $1.48 Million
Q4 2020 Feb 03, 2021	BUY	$30.19 - $45.49 $884,567 - $1.33 Million	29,300 New	29,300 $1.16 Million

274

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.59B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.